Synjardy XR is a Oral Tablet, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Boehringer Ingelheim Pharmaceuticals, Inc.. The primary component is Empagliflozin; Metformin Hydrochloride.
| Product ID | 0597-0295_2556e57c-d394-4693-b2e9-2b23921abd6b | 
| NDC | 0597-0295 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | Synjardy XR | 
| Generic Name | Empagliflozin, Metformin Hydrochloride | 
| Dosage Form | Tablet, Extended Release | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2016-12-10 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA208658 | 
| Labeler Name | Boehringer Ingelheim Pharmaceuticals, Inc. | 
| Substance Name | EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE | 
| Active Ingredient Strength | 25 mg/1; mg/1 | 
| Pharm Classes | Biguanide [EPC], Biguanides [CS], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2023-12-31 | 
| Marketing Start Date | 2016-12-10 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA208658 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2016-12-10 | 
| Marketing Category | NDA | 
| Application Number | NDA208658 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2016-12-10 | 
| Marketing Category | NDA | 
| Application Number | NDA208658 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2016-12-10 | 
| Ingredient | Strength | 
|---|---|
| EMPAGLIFLOZIN | 25 mg/1 | 
| SPL SET ID: | 8006ba29-ee3a-f852-a9bb-c8ec9b41cf66 | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 0597-0280 | Synjardy | empagliflozin, metformin hydrochloride | 
| 0597-0290 | Synjardy | empagliflozin, metformin hydrochloride | 
| 0597-0295 | Synjardy | empagliflozin, metformin hydrochloride | 
| 0597-0300 | Synjardy | empagliflozin, metformin hydrochloride | 
Mark Image Registration | Serial  | Company  Trademark Application Date  | 
|---|---|
![]() SYNJARDY  79145490  4590924 Live/Registered  | 
        Boehringer Ingelheim International GmbH  2014-02-17  |